Reichman Noah, Biso Grace Marie Nicole, Masoud Hesham
Neurology, State University of New York Upstate Medical University, Syracuse, USA.
Cureus. 2025 Feb 17;17(2):e79155. doi: 10.7759/cureus.79155. eCollection 2025 Feb.
Thrombotic thrombocytopenic purpura (TTP) is a rare hypercoagulable disorder characterized by fever, acute hemolytic anemia, thrombocytopenia, neurologic deficits, and renal failure. Due to the rarity of TTP, the infrequency of a complete TTP pentad, variable and atypical presentations, and overlap with other thrombotic microangiopathy, diagnosis is difficult to achieve. Here, we describe a middle-aged patient with recurrent multi-territory strokes, with the development of thrombocytopenia occurring later in the course of her illness without fever, hemolytic anemia, or renal failure. Etiologies for prior history of ischemic stroke were confounded by the presence of intrinsic cerebral arteriopathy at the bilateral anterior cerebral artery, middle cerebral artery, and posterior cerebral artery territories attributed to accelerated atherosclerosis from concurrent tobacco smoking and marijuana abuse. Extensive workup also disclosed inter-atrial shunt (grade III patent foramen ovale), which was subsequently treated with device closure for presumed secondary stroke prevention. Due to the development of thrombocytopenia and recurrent multi-territory strokes, an ADAMTS13 (a disintegrin and metalloprotease with a thrombospondin type 1 motif, member 13) screen was ordered and was positive. The ADAMTS13 activity was <5%, while the ADAMTS13 inhibitor Bethesda titer was notably high (1.4, normal <0.4). For acute therapy, a three-day 1 mg/kg methylprednisolone was started, and a hematology service was consulted for co-management. The patient completed four rounds of plasmapheresis while receiving 90 mg of prednisone daily. She was then started on a regimen to complete four doses of weekly rituximab. The patient improved clinically during her stay, with noted improvements in platelet count and ADAMTS13 activity. In conclusion, thrombocytopenia may appear until later in the disease course with variant presentations of TTP. A low threshold to consider atypical etiologies when pursuing workup for cryptogenic stroke should be in mind when evaluating young adults with recurrent multi-territory ischemic stroke.
血栓性血小板减少性紫癜(TTP)是一种罕见的高凝性疾病,其特征为发热、急性溶血性贫血、血小板减少、神经功能缺损和肾衰竭。由于TTP罕见,完整的TTP五联征不常见,临床表现多样且不典型,还与其他血栓性微血管病重叠,因此诊断困难。在此,我们描述一名中年患者,反复发生多区域卒中,在病程后期出现血小板减少,无发热、溶血性贫血或肾衰竭。既往缺血性卒中病史的病因因双侧大脑前动脉、大脑中动脉和大脑后动脉区域存在内在性脑动脉病变而混淆,这归因于同时吸烟和滥用大麻导致的动脉粥样硬化加速。全面检查还发现了房间隔分流(III级卵圆孔未闭),随后进行了封堵装置治疗,以预防继发性卒中。由于出现血小板减少和反复多区域卒中,遂进行了ADAMTS13(含血小板反应蛋白基序的解聚素和金属蛋白酶13)筛查,结果为阳性。ADAMTS13活性<5%,而ADAMTS13抑制剂贝塞斯达滴度显著升高(1.4,正常<0.4)。急性治疗时,开始给予为期三天的1mg/kg甲泼尼龙,并咨询血液科共同管理。患者在每日接受90mg泼尼松的同时完成了四轮血浆置换。随后开始使用方案完成四剂每周一次的利妥昔单抗治疗。患者住院期间临床症状改善,血小板计数和ADAMTS13活性均有明显改善。总之,TTP的变异型表现可能在疾病后期才出现血小板减少。在评估反复发生多区域缺血性卒中的年轻成年人时,在对不明原因卒中进行检查时应考虑非典型病因,保持较低的阈值。